{"a":[{"_":"Boehringer, Envisagenics sign $1B multi-target oncology collaboration","$":{"href":"/biotech/boehringer-envisagenics-sign-1b-multi-target-oncology-collaboration","hreflang":"en"}}]}

Summary

Boehringer Ingelheim and Envisagenics have signed a multi-year collaboration agreement valued at up to $1 billion to discover and validate tumor-specific targets for oncology drug development using AI technology.